ALLE
60
-4
AVB
57
-7
C
84
3
AAL
44
6
DLTR
54
-5
KMI
73
2
PRGO
33
-4
NSC
71
4
IRM
50
-2
RL
85
2
EMR
62
2
VNO
60
-4
PFE
26
-3
CSX
39
3
ORLY
47
-2
XOM
53
3
FIS
60
-3
ABBV
59
-3
MMC
58
-4
HUM
29
-7
ALLE
60
-4
AVB
57
-7
C
84
3
AAL
44
6
DLTR
54
-5
KMI
73
2
PRGO
33
-4
NSC
71
4
IRM
50
-2
RL
85
2
EMR
62
2
VNO
60
-4
PFE
26
-3
CSX
39
3
ORLY
47
-2
XOM
53
3
FIS
60
-3
ABBV
59
-3
MMC
58
-4
HUM
29
-7
Financhill
Back

Perspective Therapeutics Stock Predictions

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Buy
56

CATX
Perspective Therapeutics

Last Price:
$2.1600
Seasonality Move:
0.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Perspective Therapeutics Stock Forecast

  • Is Perspective Therapeutics Stock Undervalued?
    The current Perspective Therapeutics [CATX] share price is $2.5500. The Score for CATX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics Stock Go Up Next Year?

Data Unavailable

Perspective Therapeutics Stock Rating

Data Unavailable

Perspective Therapeutics Stock Price History

Is CATX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
19.0500
52-Week Low:
1.6000

Prediction Charts

Market Cap:
188.8M
Price in USD:
2.5500
Volume:
944.8K
Beta:
-72.1030

Technical Analysis

SMA50:
2.2946
SMA100:
2.7624
SMA200:
7.0195
52-Wk Change:
-85.34%

Stock Predictions

  • Is Perspective Therapeutics stock public?
    Yes, Perspective Therapeutics is a publicly traded company.
  • What is the Perspective Therapeutics stock quote today?
    The Perspective Therapeutics stock price is 2.5500 USD today.
  • How to buy Perspective Therapeutics stock online?
    You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-24 2.3600 2.4300 2.4400 2.2800
Apr-25 2.4200 2.3900 2.4500 2.3300
Apr-28 2.3900 2.4500 2.4700 2.3550
Apr-29 2.4600 2.4100 2.4800 2.3250
Apr-30 2.3700 2.4500 2.4650 2.3050
May-1 2.4500 2.4700 2.4900 2.3650
May-2 2.5000 2.5600 2.6490 2.4900
May-5 2.5500 2.4300 2.6000 2.4000
May-6 2.4000 2.2400 2.4000 2.1800
May-7 2.3300 2.3500 2.3500 2.2400
May-8 2.3500 2.4200 2.4500 2.2700
May-9 2.4200 2.3500 2.4900 2.3200
May-12 2.4000 2.5100 2.5300 2.3550
May-13 2.6100 2.5500 2.8655 2.4900

Perspective Therapeutics Earnings

Data Unavailable

Perspective Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.03 per share.

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.